We are live on ! Find out more
GAMA

Graticule Asia Macro Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 1,044.61%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+1,044.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$858M
AUM Growth
-$1.22B
Cap. Flow
-$227M
Cap. Flow %
-26.45%
Top 10 Hldgs %
66.5%
Holding
141
New
50
Increased
17
Reduced
19
Closed
51

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$20.6M
2
JUNO
Juno Therapeutics, Inc.
JUNO
+$13.5M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.64M
4
NEWR
New Relic, Inc.
NEWR
+$8.37M
5
FXI icon
iShares China Large-Cap ETF
FXI
+$8.13M

Top Sells

Rank Stock Value
1
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$34.1M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$30.5M
3
AMZN icon
Amazon
AMZN
+$29.3M
4
AAPL icon
Apple
AAPL
+$25.3M
5
ILMN icon
Illumina
ILMN
+$20.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 69.33%
2 Healthcare 11.79%
3 Consumer Discretionary 5.81%
4 Communication Services 4.75%
5 Financials 3.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
26
Incyte
INCY
$25.3B
$5.8M 0.68%
52,600
-40,282
-43% -$4.52M
RARE icon
27
Ultragenyx Pharmaceutical
RARE
$1.27B
$5.6M 0.65%
+58,100
New +$6.65M
IRS
28
IRSA Inversiones y Representaciones
IRS
$1.3B
$5.56M 0.65%
396,715
+7,994
+2% +$124K
XBI icon
29
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$5.17M 0.6%
+83,000
New +$6.54M
ASHR icon
30
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.5B
$4.85M 0.57%
150,000
+35,000
+30% +$1.29M
PAM icon
31
Pampa Energía
PAM
$4.51B
$4.6M 0.54%
301,157
+34,100
+13% +$542K
LQD icon
32
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.2B
$4.56M 0.53%
+39,300
New +$4.54M
FCX icon
33
Freeport-McMoran
FCX
$99.4B
$4.46M 0.52%
+460,000
New +$5.52M
AXS icon
34
AXIS Capital
AXS
$7.27B
$4.45M 0.52%
+82,886
New +$4.6M
ADXS
35
DELISTED
Advaxis Inc
ADXS
$4.43M 0.52%
28,858
+6,666
+30% +$1.61M
DIS icon
36
Walt Disney
DIS
$185B
$4.38M 0.51%
+42,900
New +$4.67M
NBIX icon
37
Neurocrine Biosciences
NBIX
$15.2B
$4.24M 0.49%
+106,500
New +$5.15M
CME icon
38
CME Group
CME
$98B
$4.17M 0.49%
+45,000
New +$4.28M
JUNO
39
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
$4.07M 0.47%
+100,000
New +$4.39M
GILD icon
40
Gilead Sciences
GILD
$183B
$3.63M 0.42%
+37,000
New +$4.11M
TEO icon
41
Telecom Argentina
TEO
$5.94B
$3.61M 0.42%
247,682
-76,600
-24% -$1.26M
BMY icon
42
Bristol-Myers Squibb
BMY
$130B
$2.96M 0.35%
+50,000
New +$3.17M
GGAL icon
43
Galicia Financial Group
GGAL
$6.79B
$2.92M 0.34%
163,853
+3,300
+2% +$64.1K
HOLI
44
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$2.88M 0.34%
164,800
+4,800
+3% +$93.2K
QUNR
45
DELISTED
Qunar Cayman Islands Limited
QUNR
$2.66M 0.31%
+88,300
New +$3.22M
BMA icon
46
Banco Macro
BMA
$4.86B
$2.6M 0.3%
67,655
+1,200
+2% +$53.7K
AGN
47
DELISTED
Allergan plc
AGN
$2.58M 0.3%
9,500
-47,546
-83% -$14.6M
PBYI icon
48
CALL
Puma Biotechnology
PBYI
$484M
$2.37M 0.28%
+31,500
New +$2.98M
RDUS
49
DELISTED
Radius Health, Inc.
RDUS
$2.36M 0.27%
+34,000
New +$2.36M
LKFT
50
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
$2.04M 0.24%
+50,000
New +$2.88M
1
2
3 4 5

Similar funds

CCM
Condor Capital Management Martinsville, New Jersey $1.33B AUM 19.79% 1-Year Est. Return
OCM
Ovata Capital Management Hong Kong $1.33B AUM 5.69% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.33B AUM 18.3% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.33B AUM 37.42% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.33B AUM 27.72% 1-Year Est. Return
ELC
Edgar Lomax Company Kingstowne, Virginia $1.34B AUM 25.75% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Graticule Asia Macro Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Graticule Asia Macro Advisors held 141 positions worth $858M, down 59% from $2.07B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Graticule Asia Macro Advisors withdrew a net $227M in Q3 2015, closing 51 positions and reducing 19 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $34.1M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 79% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Graticule Asia Macro Advisors opened a new position in Eli Lilly worth $20.5M.

  • Graticule Asia Macro Advisors's largest Q3 2015 buy was Eli Lilly: 244,600 shares worth $20.5M.
  • Graticule Asia Macro Advisors added most to Juno Therapeutics, Inc. in Q3 2015, an estimated $13.5M increase.
  • Graticule Asia Macro Advisors's biggest Q3 2015 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $30.5M.
  • Graticule Asia Macro Advisors fully exited State Street Financial Select Sector SPDR ETF in Q3 2015, selling an estimated $34.1M.
  • Graticule Asia Macro Advisors's ten largest holdings make up 66% of its $858M portfolio in Q3 2015.
  • Graticule Asia Macro Advisors opened 50 new positions and closed 51 in Q3 2015.
  • Graticule Asia Macro Advisors's portfolio value fell 59% quarter-over-quarter to $858M.

Based on Graticule Asia Macro Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.